Odyssean »

Transmedics Group shares owned by Odyssean

Quarter-by-quarter ownership of Transmedics Group (TMDX) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Transmedics Group

Tip: Access up to 7 years of quarterly data

All positions including Transmedics Group held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transmedics Group by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $851k 13k 66.42

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Transmedics Group

BlackRock
FMR
Vanguard Portfolio Management
Vanguard Capital Management
Citadel Advisors
State Street Corporation
Ubs Global Asset Management Americas
Geode Capital Management
Nomura Asset Management International
Susquehanna International
Hood River Capital Management
Morgan Stanley
Jane Street
Dimensional Fund Advisors
Braidwell

View all funds holding Transmedics Group